News

Independent Research Fund Denmark grants DKK 2 million towards restoring male fertility with new stem cell-based techniques

Sep 30, 2022

Infertility is a growing problem and in Denmark every 10th child is born after assisted reproduction. Male infertility plays a role in half of the cases and despite increased research focus, there are still reproductive diseases that cannot be treated. Infertility also affects pre-pubescent boys who are diagnosed with cancer and must undergo treatment that potentially destroys their ability to have children later in life.

“With our project, we want to show that testicular tissue and spermatogenic stem cells can be frozen and transplanted back into the same man to restore fertility. In this way, both men with non-obstructive azoospermia and long-term survivors of childhood cancer will have an opportunity to have children of their own,” says Christian Fuglesang S. Jensen, MD at Herlev Hospital and part of the research team with Professor Jens Sønksen, who received the DKK 2,056,227 grant end of September 2022.

Non-obstructive azoospermia is the lack of sperm cells in the seminal fluid and so far, the only option to treat it is by surgical retrieval of sperm cells from the testicles. In June 2022 Christian successfully defended his ReproUnion supported PhD and as part of the project, he completed the first randomized clinical trial with 100 Danish and Swedish men, to compare different methods to surgically retrieve sperm cells. The results are published by European Urology in October and show that sperm cells are only retrieved in up to half of the patients.

Pre-pubescent boys with cancer and men with non-obstructive azoospermia often have spermatogenic stem cells in the testicles, which can potentially be used to restore fertility.

“Today, testicular tissue from pre-pubescent boys with cancer is routinely frozen in the hope that the tissue can be used to restore fertility when they become adults. Currently, there are no clinical proven methods for restoring fertility using spermatogenic stem cells, so that is what we want to develop to help more men become biological fathers,” concludes Christian Fuglesang S. Jensen.

Independent Research Fund Denmark granted a total of DKK 127.3 million to 56 of the most original ideas contributing to patient-centered, clinical and independent research. Here you can find out more (in Danish).

Please also visit Science Direct for further information about the results published by European Urology from Christian Fuglesang S. Jensen’s PhD project:
Microdissection Testicular Sperm Extraction Versus Multiple Needle-pass Percutaneous Testicular Sperm Aspiration in Men with Nonobstructive Azoospermia: A Randomized Clinical Trial

In the ReproUnion film you can also hear what spurred Christian’s interest in andrology and male infertility and how ReproUnion has supported the inclusion of Swedish patients in the clinical trial with 100 NOA patients from Denmark and Sweden.

MORE NEWS


Welcome back Mette Bach Dyremose

We’re thrilled to welcome back Mette Bach Dyremose to the ReproUnion Management Team as she takes on a part-time role to lead ReproUnion's communication efforts! With over 20 years of experience in strategic communication, business development, and life sciences,...

read more

RUBIC Seminar – The Team Makes the Dream Work

On October 3. we gathered more than 60 people for the 2024 RUBIC Seminar, a networking event for the dedicated people involved in patient recruitment, clinical visits, sample preparation, and data analysis as well as other colleagues in contact with RUBIC in their...

read more

Defective sperm doubles the risk of preeclampsia

We’re excited to share new findings from Lund University, led by ReproUnion researcher Aleksander Giwercman. For the first time, researchers have linked specific sperm defects to pregnancy complications and adverse effects on the child’s health. The study shows that...

read more

Tour de Health

Great to have ReproUnion on the agenda on this years Tour de Health conference hosted by Ferring Pharmaceuticals arranged by Healthcare Denmark. Lars Løkke Rasmussen attended the conference and his presence highlights the growing political attention on reproductive...

read more